These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 15722820)
1. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Uchida Y; Minoshima S; Kawata T; Motoori K; Nakano K; Kazama T; Uno T; Okamoto Y; Ito H Clin Nucl Med; 2005 Mar; 30(3):170-6. PubMed ID: 15722820 [TBL] [Abstract][Full Text] [Related]
2. Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses. Ozawa N; Okamura T; Koyama K; Nakayama K; Kawabe J; Shiomi S; Yamane H; Inoue Y Radiat Med; 2006 Jan; 24(1):41-9. PubMed ID: 16715661 [TBL] [Abstract][Full Text] [Related]
3. Warthin's tumor of parotid gland on Tc-99m pertechnetate scintigraphy with lemon juice stimulation: Tc-99m uptake, size, and pathologic correlation. Miyake H; Matsumoto A; Hori Y; Takeoka H; Kiyosue H; Hori Y; Mori H; Ueyama S; Kashima K Eur Radiol; 2001; 11(12):2472-8. PubMed ID: 11734943 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors. Kim BS; Kim SJ; Pak K Ann Nucl Med; 2016 Jun; 30(5):346-54. PubMed ID: 26897010 [TBL] [Abstract][Full Text] [Related]
6. Four cases of Warthin's tumor of the parotid gland detected with FDG PET. Horiuchi M; Yasuda S; Shohtsu A; Ide M Ann Nucl Med; 1998 Feb; 12(1):47-50. PubMed ID: 9559962 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of technetium-99m-pertechnetate scintigraphy with lemon juice stimulation to evaluate Warthin's tumor. Murata Y; Yamada I; Umehara I; Okada N; Shibuya H J Nucl Med; 1998 Jan; 39(1):43-6. PubMed ID: 9443737 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of RI scintiscanning to parotid gland tumors]. Shinohara S; Yamamoto E; Tanabe M; Maetani T; Fujiwara K; Kim T Nihon Jibiinkoka Gakkai Kaiho; 2001 Sep; 104(9):852-8. PubMed ID: 11605225 [TBL] [Abstract][Full Text] [Related]
9. Parotid gland tumors: preliminary data for the value of FDG PET/CT diagnostic parameters. Hadiprodjo D; Ryan T; Truong MT; Mercier G; Subramaniam RM AJR Am J Roentgenol; 2012 Feb; 198(2):W185-90. PubMed ID: 22268210 [TBL] [Abstract][Full Text] [Related]
10. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy. Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography in Warthin's tumor mimicking malignancy impacts the evaluation of head and neck patients. Rassekh CH; Cost JL; Hogg JP; Hurst MK; Marano GD; Ducatman BS Am J Otolaryngol; 2015; 36(2):259-63. PubMed ID: 25523505 [TBL] [Abstract][Full Text] [Related]
12. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results. Karaman CZ; Tanyeri A; Özgür R; Öztürk VS Dentomaxillofac Radiol; 2021 May; 50(4):20200391. PubMed ID: 33237812 [TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration as a diagnostic modality for Warthin tumors identified as fluorodeoxyglucose positron emission tomography/computed tomography-positive. Kowalewski A; Tissot H; Jehanno N; Bakuła Zalewska E; Choussy O; Lesnik M; Badois N; Rougier G; Klijanienko J Diagn Cytopathol; 2024 Feb; 52(2):116-122. PubMed ID: 37991130 [TBL] [Abstract][Full Text] [Related]
14. Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors? Kendi AT; Magliocca KR; Corey A; Galt JR; Switchenko J; Wadsworth JT; El-Deiry MW; Schuster DM; Saba NF; Hudgins PA AJR Am J Roentgenol; 2016 Sep; 207(3):635-40. PubMed ID: 27276388 [TBL] [Abstract][Full Text] [Related]
15. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET. Khan N; Oriuchi N; Ninomiya H; Higuchi T; Kamada H; Endo K Ann Nucl Med; 2004 Jul; 18(5):409-17. PubMed ID: 15462403 [TBL] [Abstract][Full Text] [Related]
16. 99mTcO4- accumulation in scintigraphy and expression of Na+/I- symporter in salivary gland tumors. Akai A; Yamamura Y; Nonaka M; Yoshihara T Auris Nasus Larynx; 2014 Dec; 41(6):532-8. PubMed ID: 25199743 [TBL] [Abstract][Full Text] [Related]
17. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management. Basu S; Houseni M; Alavi A Nucl Med Commun; 2008 Apr; 29(4):367-73. PubMed ID: 18317302 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of conventional whole-body ¹⁸F-FDG PET/CT in the incidental findings of parotid masses. Wang HC; Zuo CT; Hua FC; Huang ZM; Tan HB; Zhao J; Guan YH Ann Nucl Med; 2010 Oct; 24(8):571-7. PubMed ID: 20640540 [TBL] [Abstract][Full Text] [Related]